首页> 美国卫生研究院文献>The Oncologist >A Multicenter Analysis of Immune Checkpoint Inhibitors as Adjuvant Therapy Following Treatment of Isolated Brain Metastasis

【2h】

A Multicenter Analysis of Immune Checkpoint Inhibitors as Adjuvant Therapy Following Treatment of Isolated Brain Metastasis

机译：免疫检查点抑制剂的多中心分析作为孤立脑转移治疗后辅助治疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The objective of this work was to characterize outcomes of patients with isolated brain metastases managed with local therapy followed by immune checkpoint inhibitor (ICI) therapy.

机译：这项工作的目的是将患者患者的结果表征在局部治疗中治疗的患者的结果，然后进行免疫检查点抑制剂（ICI）治疗。

著录项

期刊名称 The Oncologist
作者
J. Randall Patrinely Jr.; Elisa Funck‐Brentano; Khang Nguyen; Suthee Rapisuwon; Joe‐Elie Salem; Geoffrey T. Gibney; Matteo Carlino; Douglas B. Johnson;
展开▼
作者单位

展开▼
年(卷),期 2021(26),3
年度 2021
页码 e505–e507
总页数 3
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. A Multicenter Analysis of Immune Checkpoint Inhibitors as Adjuvant Therapy Following Treatment of Isolated Brain Metastasis [J] . J. Randall Patrinely Jr., Elisa Funck-Brentano, Khang Nguyen, The oncologist . 2021,第3期

机译：免疫检查点抑制剂的多中心分析作为分离脑转移治疗后辅助治疗的佐剂治疗
2. Previous Immune Checkpoint Inhibitor Treatment to Increase the Efficacy of Docetaxel and Ramucirumab Combination ChemotherapyPrevious Immune Checkpoint Inhibitor Treatment to Increase the Efficacy of Docetaxel and Ramucirumab Combination Chemotherapy [J] . Harada Daijiro, Takata Kenji, Mori Shunta, Anticancer Research: International Journal of Cancer Research and Treatment . 2019,第9期

机译：以往的免疫检查点抑制剂治疗，增加多西紫杉醇和拉姆梭拉组合组合化疗的疗效术治疗免疫检查点抑制剂治疗，增加了多西紫杉醇和拉姆索姆拉姆联合化疗的疗效
3. Immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy alone versus immune checkpoint inhibitor (anti-CTLA-4, anti-PD-1) therapy in combination with anti-RANKL denosumuab in malignant melanoma: a retrospective analysis at a tertiary care center [J] . Afzal Muhammad Z., Shirai Keisuke Melanoma research . 2018,第4期

机译：免疫检查点抑制剂（抗CTLA-4，抗PD-1）治疗与免疫检查点抑制剂（抗CTLA-4，抗PD-1）治疗组合在恶性黑色素瘤中的抗Rankl Denosumuab组合：回顾性分析在一个第三级护理中心
4. ENGINEERING AND PRE-CLINICAL EVALUATION OF A HUMAN ENZYME IMMUNE CHECKPOINT INHIBITOR FOR CANCER THERAPY [C] . Everett Stone, John Blazek, Christos Karamitros, Enzyme Engineering Conference . 2018

机译：癌症治疗人酶免疫检查点抑制剂的工程与临床评价
5. Effects of EGCG and DAC Combinational Treatment on Treating Triple Negative Breast Cancer and Aiding Immune Checkpoint Blockage Therapies [D] . Wang, Zixu. 2019

机译：EGCG和DAC组合治疗对治疗三重阴性乳腺癌的影响及辅助免疫检查点梗阻疗法
6. Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immune checkpoint inhibitors for first‐ or second‐line treatment of advanced gastric and gastro‐esophageal junction cancer [O] . Berna C Özdemir, Markus Moehler, Nicholas LX Syn, -1

机译：免疫检查点抑制剂加化疗与化学疗法或免疫检查点抑制剂相结合用于一线或二线晚期胃癌和胃食管连接癌
7. A Multicenter Analysis of Immune Checkpoint Inhibitors as Adjuvant Therapy Following Treatment of Isolated Brain Metastasis [O] . J. Randall Patrinely, Elisa Funck‐Brentano, Khang Nguyen, 2020

机译：免疫检查点抑制剂的多中心分析作为孤立脑转移治疗后辅助治疗

A Multicenter Analysis of Immune Checkpoint Inhibitors as Adjuvant Therapy Following Treatment of Isolated Brain Metastasis

摘要

著录项

相似文献

相关主题

期刊订阅